This application is for continuation of a program, first begun in 2002, for training in cancer biostatistics. The need for well trained statistical scientists in biomedical research is massive and it is not being met by the number of graduates being produced by biostatistics departments across the US.
The aim of the training program is to increase the participation in cancer research of biostatisticians who are educated not only in the powerful methods of modern statistics, but also in the biology and epidemiology of cancer, the current body of knowledge about the etiology of the disease, its detection, prevention, natural history and treatment. This training program will provide biostatisticians with the requisite scientific knowledge to understand current issues in cancer research, and training in statistical and epidemiological.techniques and research methodology related to cancer. The goals of the training program are to give students who are obtaining a Ph.D. in Biostatistics or a related field (i) a solid understanding of cancer biology, (ii) experience and ability to communicate and collaborate with cancer scientists, (iii) understanding of recent developments in cancer requiring innovative statistical research and (iv) independent research skills. We propose to have four predoctoral trainees. The interdisciplinary program that will enable the trainees to obtain knowledge and experience in an area of cancer research and to participate as a biostatistician in an active research program under the direction of a mentor in biostatistics and a cancer scientist. The cancer research experience will be facilitated by the Cancer Center Biostatistics Unit. In addition to the biostatistics courses, the trainees will be required to take courses in cancer epidemiology, biology and genetics. The strong programmatic activities include two specifically designed courses on biostatistical issues in cancer, visits to cancer research labs and meetings with invited visitors. The training program is supported by primary faculty from the departments of Biostatistics and related fields and supporting faculty from the University of Michigan Comprehensive Cancer Center.
|Muenz, Daniel G; Braun, Thomas M; Taylor, Jeremy Mg (2018) Modeling adverse event counts in phase I clinical trials of a cytotoxic agent. Clin Trials 15:386-397|
|Hoban, Connor W; Beesley, Lauren J; Bellile, Emily L et al. (2018) Individualized outcome prognostication for patients with laryngeal cancer. Cancer 124:706-716|
|Bhave, Manali A; Speth, Kelly A; Kidwell, Kelley M et al. (2018) Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer. Clin Breast Cancer 18:168-174.e2|
|Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647|
|Cheng, Wenting; Taylor, Jeremy M G; Vokonas, Pantel S et al. (2018) Improving estimation and prediction in linear regression incorporating external information from an established reduced model. Stat Med 37:1515-1530|
|Kidwell, Kelley M; Seewald, Nicholas J; Tran, Qui et al. (2018) Design and Analysis Considerations for Comparing Dynamic Treatment Regimens with Binary Outcomes from Sequential Multiple Assignment Randomized Trials. J Appl Stat 45:1628-1651|
|Birkeland, Andrew C; Beesley, Lauren; Bellile, Emily et al. (2017) Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck 39:2512-2518|
|Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668|
|Suresh, Krithika; Taylor, Jeremy M G; Spratt, Daniel E et al. (2017) Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model. Biom J 59:1277-1300|
|Gottschlich, Anna; Rivera-Andrade, Alvaro; Grajeda, Edwin et al. (2017) Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala. J Glob Oncol 3:444-454|
Showing the most recent 10 out of 93 publications